ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB/PI3K-AKT signaling
Xu Zhao(Second Hospital of Tianjin Medical University), Tongwei Chu(Army Medical University), Hao Qiu(Army Medical University), Xuan Wen(Army Medical University), Ying Zhang(Boston Children's Hospital), Xianming Huang(Army Medical University), Chenhui Cai(Army Medical University), Chao Tang(North Sichuan Medical University), Sizhen Yang(Army Medical University)
Cited by 1
Related Papers
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
|The Lancet Oncology|2017|780
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
|Cell Host & Microbe|2021|140
Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
|PLoS ONE|2014|129
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore
|Nature Methods|2024|122
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
|Cancer Immunology Immunotherapy|2018|111